VOYA INVESTMENT MANAGEMENT LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$8,175,209
+1.2%
515,136
+20.3%
0.01%
+10.0%
Q2 2023$8,079,945
+204.4%
428,190
-38.1%
0.01%
+233.3%
Q1 2023$2,654,211
-26.5%
691,201
-5.1%
0.00%
-40.0%
Q4 2022$3,611,787
-26.8%
728,183
-29.5%
0.01%
-28.6%
Q3 2022$4,935,355
+1172.0%
1,032,501
+1099.3%
0.01%
+600.0%
Q2 2022$388,000
-1.0%
86,089
+4.4%
0.00%0.0%
Q1 2022$392,000
-33.3%
82,430
+4.0%
0.00%0.0%
Q4 2021$588,000
-77.4%
79,284
-82.7%
0.00%
-80.0%
Q3 2021$2,601,000
-19.7%
458,669
-6.7%
0.01%
-16.7%
Q2 2021$3,240,000
-21.5%
491,724
-3.6%
0.01%
-25.0%
Q1 2021$4,130,000
+10.9%
509,856
-11.7%
0.01%0.0%
Q4 2020$3,723,000
+1623.6%
577,228
+864.2%
0.01%
Q3 2020$216,000
-21.5%
59,8630.0%0.00%
-100.0%
Q2 2020$275,000
-3.8%
59,863
-28.6%
0.00%0.0%
Q1 2020$286,000
-21.2%
83,859
+18.0%
0.00%0.0%
Q4 2019$363,000
+150.3%
71,058
+18.9%
0.00%
Q3 2019$145,000
+11.5%
59,7480.0%0.00%
Q2 2019$130,000
-96.6%
59,748
-95.8%
0.00%
-100.0%
Q1 2019$3,866,000
-63.9%
1,426,439
-36.1%
0.01%
-65.4%
Q4 2018$10,718,000
-53.3%
2,232,721
-7.9%
0.03%
-44.7%
Q3 2018$22,955,000
+27.6%
2,424,017
+31.1%
0.05%
+23.7%
Q2 2018$17,993,000
+3803.0%
1,849,256
+4117.8%
0.04%
+3700.0%
Q1 2018$461,000
+64.1%
43,8440.0%0.00%0.0%
Q4 2017$281,000
-14.6%
43,844
+1.9%
0.00%0.0%
Q3 2017$329,000
+2.8%
43,031
-4.5%
0.00%0.0%
Q2 2017$320,000
+101.3%
45,066
+10.0%
0.00%
Q1 2017$159,000
+89.3%
40,9610.0%0.00%
Q4 2016$84,000
-23.6%
40,9610.0%0.00%
Q3 2016$110,000
-12.7%
40,9610.0%0.00%
Q2 2016$126,000
-63.9%
40,9610.0%0.00%
-100.0%
Q1 2016$349,000
-37.2%
40,9610.0%0.00%0.0%
Q4 2015$556,000
+41.5%
40,9610.0%0.00%0.0%
Q3 2015$393,000
-42.7%
40,961
-14.1%
0.00%
-50.0%
Q2 2015$686,000
+60.7%
47,7050.0%0.00%
+100.0%
Q1 2015$427,000
+46.7%
47,7050.0%0.00%0.0%
Q4 2014$291,000
-42.4%
47,7050.0%0.00%0.0%
Q3 2014$505,000
-10.6%
47,7050.0%0.00%0.0%
Q2 2014$565,000
-20.6%
47,7050.0%0.00%
-50.0%
Q1 2014$712,000
+1.7%
47,7050.0%0.00%0.0%
Q4 2013$700,000
-13.8%
47,7050.0%0.00%0.0%
Q3 2013$812,000
+2.7%
47,7050.0%0.00%0.0%
Q2 2013$791,00047,7050.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders